Senti Bio to Showcase Innovative Gene Therapies at SEED 2025
Senti Biosciences, Inc. (Nasdaq: SNTI), a pioneering clinical-stage biotechnology company, is set to present at the highly anticipated 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference. This premier event, taking place from June 23 to June 26, 2025, is an essential gathering for synthetic biologists from around the globe.
Presentation Details
During the SEED Conference, Senti Bio will take the stage to share insights on a vital topic within the realm of synthetic biology and cancer treatment.
Session: Building with Biology
Title: Solving the Grand Challenge of Tumor-Specific Therapies with Logic-Gated Cells
Presenter: Timothy Lu, MD, PhD, Co-Founder and CEO of Senti Biosciences
Date and Time: Tuesday, June 24, 2025, at 1:20 PM CT
About the SEED Conference
Since its launch in 2014, the SEED Conference has established itself as a cornerstone event for synthetic biologists to collaborate and share their revolutionary findings. This gathering not only brings together established experts but also welcomes emerging talents. With over 5,000 professionals attending since its inception, SEED serves as a dynamic environment to foster innovation, explore cutting-edge research, and discuss transformative applications in synthetic biology.
Innovative Approaches in Gene Therapy
Senti Bio is committed to creating precise and effective therapies for patients suffering from severe, life-threatening conditions. The company's unique Gene Circuit platform is designed to develop innovative cell and gene therapies that give exciting possibilities for targeting tumors while minimizing damage to healthy cells. Through this approach, they aim to provide new hope for individuals battling such challenging diseases.
Broadening the Scope of Therapies
Senti Bio's pipeline consists of various cell therapies integrated with Gene Circuits that address complex liquid and solid tumor challenges. Their developments have shown preclinical potential not just in oncology but also in areas beyond it, expanding the potential applications of their synthetic biology innovations.
Engagement with the Community
The company actively engages with its stakeholders and the broader community through various platforms to keep them informed about developments and insights. Investors and interested parties can stay updated via Senti Bio's official website, where they share a wealth of information including company news, presentations, and important filings.
For more about Senti Bio, visit their official site at: www.sentibio.com. You can also follow their updates on social media.
Frequently Asked Questions
What is the SEED Conference?
The SEED Conference is a premier event for synthetic biologists to share their work, network, and explore innovations in synthetic biology.
What will Senti Bio present at the SEED Conference?
Senti Bio will present their work on tumor-specific therapies using logic-gated cells to address cancer challenges.
Who is the presenter from Senti Bio?
The presentation will be given by Timothy Lu, MD, PhD, Co-Founder and CEO of Senti Biosciences.
When is the SEED Conference taking place?
The SEED Conference will occur from June 23 to June 26, 2025.
How can I find more information about Senti Bio?
Information regarding Senti Bio, their research, and updates can be found on their official website and social media platforms.
